Ilan Daskal
CIK 1446964 · EVP, CFO · last filed 2025-12-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.13M
Companies
7
Total Filings
67
Lifetime Open-Market Net
-$10.08M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIAV | EVP, CFO | 155,032 | $35.10 | $5.44M | -$3.73M | 9 | 2025-12-03 |
| BIO.B | EVP, Chief Financial Officer | 2,206 | $309.37 | $682.5K | -$2.40M | 12 | 2023-09-06 |
| NATUS MEDICAL INC (NTUS) Delisted | Director | 0 | $32.96 | $0 | -$68.7K | 6 | 2022-07-21 |
| IXIA (XXIA) Delisted | Director | 16,140 | — | — | $0 | 2 | 2016-06-07 |
| SUNE | EVP & CFO Designee | 2,000 | $2.15 | $4.3K | $0 | 1 | 2016-04-11 |
| CEPHEID (CPHD) Delisted | EVP, Chief Financial Officer | 10,000 | — | — | $0 | 1 | 2015-04-13 |
| INTERNATIONAL RECTIFIER CORP /DE/ (IRF) Delisted | Executive Vice President & CFO | 0 | — | — | -$3.88M | 33 | 2015-01-13 |
Recent Filings · Page 3 of 7
67 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-05 | BIO.B | Mixed | −900 | -$1.30M | EDGAR |
| 2021-06-21 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +5,214 | $150.0K | EDGAR |
| 2021-06-15 | NATUS MEDICAL INC (NTUS) Delisted | Sell (S) | −2,500 | -$68.7K | EDGAR |
| 2021-04-09 | BIO.B | Mixed | +450 | -$148.1K | EDGAR |
| 2020-09-04 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2020-06-22 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +3,560 | $75.0K | EDGAR |
| 2020-04-09 | BIO.B | Mixed | +457 | -$97.9K | EDGAR |
| 2020-03-20 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +7,588 | $150.0K | EDGAR |
| 2019-04-09 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | — | Disp (D) | −16,140 | -$317.2K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.